PT Kedoya Adyaraya Tbk Stocks

IDR 980Last Updated 25.02.2025

Issuer Rating

3/7

Performance

Average

Risk

Considerable

Recommendation

Sell

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
IDR 980
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Slightly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. The company provides healthcare services in various specialties, such as general surgery, orthopedic surgery, urology, cardiothoracic surgery, plastic surgery, neurosurgery, internist, nephrologist, endocrinologist & metabolic, obstetrics and gynecology specialist, cardiology, neurology, pulmonology, ophthalmologist, hyperbaric, pediatrician, acupuncture, medical rehabilitation, speech therapy, oral and maxillofacial, prosthodontics, dentists,...

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks